Keyphrases
During Pregnancy
100%
Lactation
100%
Pharmacogenetics
100%
Selective Serotonin Reuptake Inhibitors
100%
Serotonin-norepinephrine Reuptake Inhibitors
100%
Genotype
66%
Late Pregnancy
33%
Metabolism
33%
Adverse Effects
16%
Pregnancy Outcome
16%
Exposure during Pregnancy
16%
Liver
16%
Paroxetine
16%
Fluoxetine
16%
Serum Concentration
16%
Cytochrome P450 2D6 (CYP2D6)
16%
Polymorphism
16%
Predictive Value
16%
Pregnancy Disorders
16%
Ultrarapid Metabolizer
16%
Low Serum
16%
Increased Dose
16%
Steady-state Concentration
16%
Potential Interaction
16%
Pregnancy Women
16%
Citalopram
16%
Escitalopram
16%
Venlafaxine
16%
Metabolic Clearance
16%
Metabolic Level
16%
Cytochrome P450 Enzymes
16%
Serotonin Transporter
16%
CYP2C19
16%
SLC6A4
16%
Extensive Metabolizer
16%
Duloxetine
16%
Biochemistry, Genetics and Molecular Biology
Serotonin
100%
Selective Serotonin Reuptake Inhibitor
100%
Reuptake
100%
Serotonin-Norepinephrine Reuptake Inhibitor
100%
Pharmacogenetics
100%
Enzyme
40%
Metabolic Pathway
40%
Genotyping
40%
Third Trimester Pregnancy
40%
Progeny
20%
Blood Level
20%
CYP2D6
20%
Promoter Region
20%
Paroxetine
20%
Duloxetine
20%
Concentration at Steady-State
20%
Escitalopram
20%
Venlafaxine
20%
Fluoxetine
20%
Citalopram
20%
Metabolic Clearance
20%
Serotonin Transporter
20%
CYP2C19
20%
Pharmacology, Toxicology and Pharmaceutical Science
Serotonin
100%
Pharmacogenetics
100%
Selective Serotonin Reuptake Inhibitor
100%
Reuptake Inhibitor
100%
Serotonin-Norepinephrine Reuptake Inhibitor
100%
Adverse Event
20%
Paroxetine
20%
Fluoxetine
20%
CYP2D6
20%
Venlafaxine
20%
Citalopram
20%
Escitalopram
20%
CYP2C19
20%
Duloxetine
20%
Serotonin Transporter
20%
Neuroscience
Serotonin
100%
Reuptake Inhibitor
100%
Selective Serotonin Reuptake Inhibitor
100%
Serotonin-Norepinephrine Reuptake Inhibitor
100%
Metabolic Pathway
40%
Cytochrome P450 2D6
20%
Adverse Effect
20%
Promoter Region
20%
Fluoxetine
20%
Paroxetine
20%
Escitalopram
20%
Duloxetine
20%
Cytochrome P450 2C19
20%
Venlafaxine
20%
Serotonin Transporter
20%
Citalopram
20%